Skip to main content

David G. Conway


[email protected]



David focuses his practice on transactional work, including private acquisitions, portfolio company add-ons, exits, and co-investments, and on general corporate matters such as corporate reorganizations, corporate governance issues, and general commercial contracts. His clients range from family offices to global corporations. 

Prior to joining Mintz, David was an associate in the global transactions practice of an international law firm in New York City. During his tenure, he was the lead transaction and corporate governance associate for multiple mid-market and private equity platforms. 

Earlier David was selected to work as a visiting lawyer in the New York office of a global law firm, where he handled a wide range of transactional and general corporate matters for leading private equity, corporate, and entertainment clients. 

Before practicing law in the United States, David was an associate in the private equity and private M&A practice of a multinational law firm based in Australia. In addition to his transactional work with the firm’s private equity team in Sydney, David regularly conducted research for potential private equity targets and contributed to the firm’s private equity report as well as external publications targeting the startup community. 

After completing his law degree at University of Technology Sydney, David earned a Graduate Diploma of Legal Practice from the College of Law in Sydney. 

In 2011, David was a summer analyst with the investment banking and merchant banking compliance group at Goldman Sachs. 


  • University of Technology, Sydney (JD)
  • Georgetown University (BS)
  • College of Law - Sydney (GD, Legal Practice)


Mergers & Acquisitions Viewpoints Thumbnail Image

COVID-19 and Poison Pills: The Right Prescription?

April 30, 2020 | Advisory | By Matthew Gardella, Scott M. Stanton, David G. Conway

The coronavirus pandemic continues to have profound effects on the U.S. and global economies. Investor concerns about the impact of COVID-19 and government-imposed restrictions on individuals and businesses have led to unprecedented market volatility. Further material volatility is anticipated. In this environment, publicly traded companies may want to evaluate the adequacy of their corporate defenses to protect their stockholders from such predatory activities.
Read more